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Abstract
Background:  Few studies on bacteraemia in Africa have been published. We aimed to
prospectively identify the causative organisms of bacteraemia in The Gambia and their relation to
clinical diagnoses, outcome and antimicrobial susceptibility.
Methods: Between November 2003 and February 2005 we studied those admitted to the Medical
Research Council hospital who were suspected of having bacteraemia. We documented clinical
features, outcome, pathogens identified and their susceptibility patterns, and searched for factors
associated with bacteraemia.
Results: 871 patients were admitted and had a blood culture taken. The median age was 2 years
(range 2 months to 80 years) and 36 of 119 tested were HIV positive; 54.5% were male. 297 (34%)
had a positive result and 93 (10.7% overall) were considered a genuine pathogen. Those with
bacteraemia were more likely to die in hospital (OR 2.79; 1.17–6.65, p = 0.017) and to have a high
white cell count (WCC; OR 1.81;95% CI 1.09–3.02; p = 0.022). Three organisms accounted for
73% of bacteraemias: Streptococcus pneumoniae (45.2%),  Staphylococcus aureus (18.3%) and
Escherichia coli (9.7%) while non-typhoidal salmonellae (NTS) accounted for 8.6%. Antimicrobial
susceptibility of S. pneumoniae was very high to penicillin (97.5%); high resistance was found to co-
trimoxazole.  S. aureus was generally highly susceptible to cloxacillin, gentamicin and
chloramphenicol. E. coli and NTS were all susceptible to ciprofloxacin and mostly susceptible to
gentamicin. Thirteen (33%) S. pneumoniae isolates were of serotypes contained in a 7-valent
pneumococcal conjugate vaccine and 20 (51.3%) were of the same serogroup.
Conclusion: In The Gambia, those with bacteraemia are more likely than those without to die in
hospital and to have a raised peripheral blood WCC. S. pneumoniae is the most common organism
isolated. Introduction of a pneumococcal conjugate vaccine can be expected to lead to a reduction
in disease incidence.
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Background
There is a large excess of mortality in sub-Saharan Africa,
particularly in children: under 5 year old mortality rates of
100–250 per 1,000 compare with 10–30 per 1,000 in
developed countries [1]. It is increasingly clear that inva-
sive bacterial infections are a major contributor to this
excess [2], with incidence rates confirmed to be much
higher than those reported in developed countries [3].
However there is a paucity of information as to the rela-
tive contribution of different organisms to bacterial infec-
tions in sub-Saharan Africa and how this varies across a
full range of age groups.
The virtual elimination of Haemophilus influenzae type b
(Hib) disease in The Gambia [4] has changed the relative
importance of other pathogens in the etiology of invasive
bacterial infection. It is thought that Streptococcus pneumo-
niae is probably the predominant organism, as indicated
by the success of a 9-valent pneumococcal conjugate vac-
cine in children, which included an overall mortality ben-
efit [5]. We prospectively studied patients admitted to the
Medical Research Council (MRC) hospital in Greater Ban-
jul (the opposite end of the country to the location of the
pneumococcal vaccine trial) who were suspected of hav-
ing bacteraemia, to identify the causative organisms in
relation to clinical diagnoses and their antimicrobial sus-
ceptibility patterns, and to identify differences between
those with bacteraemia and those without.
Methods
Setting
The Gambia is situated 12° north of the equator and has
a limited rainy season from June to October and most
malaria transmission occurs from July to November. The
MRC in The Gambia has a 42-bed ward which serves as a
primary and tertiary health facility for a mainly urban
population. It does not provide any surgical, obstetric or
neonatal care. Such patients are referred to the Royal Vic-
toria Teaching Hospital in Banjul, which has facilities to
manage them.
Participants
We conducted a study to assess clinical and bacteriologi-
cal characteristics of bacteraemia episodes in patients
admitted at the MRC ward from November 2003 to Feb-
ruary 2005. The decision to take blood samples for culture
rested solely on the attending physician's clinical impres-
sion and judgment. Verbal consent was obtained prior to
blood sampling. The study was approved by the joint
Gambia government-MRC ethics committee.
Data gathering
Case notes of all patients admitted were reviewed daily to
identify those who had blood cultures as part of their rou-
tine workup. We developed, piloted and finalised a stand-
ardized questionnaire to record socio-demographic
characteristics, clinical symptoms, tobacco and alcohol
use, prior antibiotics, steroid and immunosuppressive
agents use, history of concurrent medical conditions (e.g.
diabetes, cancer, HIV, sickle cell disease), anthropometric
and physical signs and the results of investigations. When
antibiotics were prescribed, the name, route and time of
administration were noted. The clinical diagnosis and in-
hospital outcome were recorded. An infectious diseases
physician confirmed the final diagnosis for each case after
review of the respective form. The decision to request any
investigation was based solely on the attending physi-
cian's clinical judgment and each patient received routine
medical care.
Blood cultures
Bacterial isolates were obtained from blood using an auto-
mated blood-culture system BACTEC 9050, (Becton Dick-
inson, Temse, Belgium). Commercially produced BD
BACTEC™ PEDS PLUS™/F culture vials were used for spec-
imens obtained from children aged one month to 15 years
and BD BACTEC™ Plus Aerobic/F* and Plus Anaerobic/F*
culture vials for specimens from adults aged >15 years by
direct inoculation of culture media at the patient's bedside
following manufacturer's instructions for quality control
and blood volume requirements. Whenever in sufficient
blood volume was obtained only the Plus Aerobic/F* vial
was inoculated. Whenever there was shortage of commer-
cial vials each of Tryptone Soya Broth (TSB) and Brain
Heart Infusion (BHI) culture media were used for speci-
mens from adults and TSB only was used for specimens
from children. We used standard microbiological proce-
dures as described previously [6]. Further identification
was by cultural morphology and biochemical methods. In
addition, serotyping of the pneumococcal isolates was
performed with capsular and factor-typing sera (Statens
Serum Institut, Copenhagen, Denmark) using an anti-
body coated latex agglutination assay. Antimicrobial sen-
sitivity patterns were determined by Kirby-Bauer disk
diffusion test using interpretative criteria described previ-
ously [6]. The microbiology laboratory submits to the
external quality assurance programme of the United King-
dom National External Quality Assessment Service.
Isolates were classified as contaminants if they were
known to be a common skin contaminant, if there was
scanty growth not on the line of inoculum that failed to
grow on subculture, or if the isolate was obtained from
the TSB aerobic bottle only after both bottles (TSB and
BHI) had been inoculated with blood.
Malaria slides were stained by Field's stain and examined
using a ×100 oil immersion lens. Testing for HIV-1 or
HIV-2 infection was by competitive enzyme linked immu-
nosorbent assays (Wellcome Laboratories, Kent, UK) andBMC Infectious Diseases 2007, 7:2 http://www.biomedcentral.com/1471-2334/7/2
Page 3 of 8
(page number not for citation purposes)
Western blot (Diagnostics Pasteur, Marnes-la-Coquette,
France).
Data analysis
All data were double-entered into an ACCESS database
and checked for errors. We compared those with bacterae-
mia with those without. Weight for age was standardized
using the CDC 2000 growth reference [7]. We defined the
wet season as from June to November and the dry season
from December to May. We defined tachycardia as >= 160
Beats per minute in infants under 12 months of age, 140
in 1 to 5 year old children and 120 in those 6 years old
and over. A raised respiratory rate was >50 breaths per
minute in infants and >40 in other age groups. A clinical
diagnosis of severe malnutrition was defined as either vis-
ible severe wasting or Kwashiokor. Septicaemia was
defined as the presence of bacteraemia in the absence of a
focus of infection. We assessed possible risk factors for
bacteraemia by Chi-Square test and, in addition to age
and sex that were included a priori, considered those with
a p value of <= 0.15 for a multi-variable logistic regression
model. The explanatory variables in the final adjusted
model were age (continuous variable), sex, temperature
(categorical variable) and white cell count (categorical
variable). A separate model compared the outcome of
those with bacteraemia to those without, adjusting for the
above variables. Analyses were conducted using Stata soft-
ware (version 8; Stata Corp, College Station, TX).
Results
During the study period, 2712 patients were admitted to
the MRC ward, the median age was 5 years (range 2
months to 80 years) and 871 underwent phlebotomy for
blood culture. The median age of these patients was 2
years (range 2 months to 80 years) and 54.5% were male
(table 1). Nine patients had taken corticosteroids in the
last month, one had a history of malignancy, 6 were
known to be diabetic. Two hundred and forty nine
patients had a screening test for sickle cell disease, 58
(23.3%) were positive. The median duration of stay was 4
days (range: 1 to 45 days). Forty nine (5.5%) patients died
in hospital. The overall mortality in the hospital was 6%
during the period. One hundred and nineteen patients
had known HIV status or were tested during the admis-
sion because of one or more clinical indication; 36
(30.2%) were HIV positive.
Of those who had a blood culture taken, 297 (34%) had
a positive result and 93 (10.7% overall) were considered
to be a genuine pathogen (Figure 1). Those whose blood
culture grew a contaminant were excluded from further
analyses because of the possibility of masking of a true
bacteraemia. Of those with bacteraemia, the same organ-
ism was obtained from another normally sterile site in 12
(12.9%) cases.
Those with bacteraemia were more likely to die in hospital
and, while this was not significant by Chi-Square, in an
adjusted model it was significant (OR 2.74; 95% CI 1.15–
6.53; p = 0.022). Those with bacteraemia were more likely
to have a temperature >= 38°C, although in the adjusted
model this lost significance (OR 1.42; 95% CI 0.9–2.25; p
= 0.14), having been subject to confounding by WCC.
Those with a WCC of at least 10 × 109/L at presentation
were also more likely to be bacteraemic, remaining signif-
icant in the adjusted model (OR 1.81;95% CI 1.09–3.02;
p = 0.022). For those with a WCC of at least 15 × 109/L,
the adjusted OR was 1.97 (95% CI 1.23–3.15; p = 0.005).
Almost 40% of those in the study had a clinical diagnosis
of pneumonia and the distribution of clinical diagnoses
were similar between the two groups. Of those with pneu-
monia 276 (83%) had an xray, and 263 (95.3%) were
assessed as being abnormal.
Three organisms combined to account for 73% of all
bacteraemias (table 2); S. pneumoniae (45.2%), Staphyloco-
ccus aureus (18.3%) and Escherichia coli (9.7%) while non-
typhoidal salmonellae(NTS) accounted for 8.6% of iso-
lates. Of note, H. influenzae accounted for 2 isolates (1 Hib
and 1 Hi non-serotypable) and Neisseria spp. accounted
for 1 isolate (Figure 1). None of the organisms detected
were more likely to be identified in the wet season. In
those who were bacteraemic, 2 of 10 with malaria on
blood film had NTS as opposed to 4 of 70 who had a neg-
ative blood film, although this difference was not signifi-
cant (p = 0.12). S. pneumoniae and S. aureus were relatively
evenly distributed across the age groups. In contrast, 5 of
the 9 E. coli isolates were found in infants, although only
one was under 6 months of age. Of the 8 (8.6%) bacterae-
mic patients who died, 3 had S. pneumoniae, 2 had S.
aureus, 2 had NTS and 1 had Proteus spp.
Of 39 isolates of S. pneumoniae that were characterised fur-
ther by serotyping, 14 serotypes/groups
(1,5,14,23F,6A,19A,6B,,4,9V,9L,10,15,18C,22) were
identified, two (1 and 5) accounted for 16 (41%) of the
isolates. Thirteen (33%) were of serotypes contained in a
7-valent pneumococcal conjugate vaccine (4, 6B, 9V, 14,
18C, 19F, and 23F) and 20 (51.3%) were of a 7-valent vac-
cine serogroup.
Isolates of S. pneumoniae (39, 97.5%) were highly suscep-
tible to penicillin (Table 3), ampicillin (100%) and chlo-
ramphenicol (97.6%). They were moderately susceptible
to tetracycline (65.9%) and only poorly susceptible to co-
trimoxazole (5%). S. aureus isolates were all susceptible to
cloxacillin, gentamicin and chloramphenicol; moderately
susceptible to co-trimoxazole (66.7%) and poorly suscep-
tible to tetracycline (33%) and penicillin (8%). Among
Gram-negative bacteria, all isolates of E. coli (9) and NTS
(5–7%) were susceptible to ciprofloxacin. In addition, E.BMC Infectious Diseases 2007, 7:2 http://www.biomedcentral.com/1471-2334/7/2
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coli  isolates were highly susceptible to gentamicin
(88.9%) and moderately susceptible to chloramphenicol
(66.7%), poorly susceptible to co-trimoxazole (22%) and
completely non-susceptible to ampicillin. Non-typhoidal
isolates were also susceptible to gentamicin (100%), tetra-
cycline (80%), co-trimoxazole (71%), chloramphenicol
(66.7%) and ampicillin (57%).
Discussion
In this study we have shown that Gambian patients with
bacteraemia are more likely than those without to die in
hospital and to have a raised peripheral blood WCC.
Three organisms accounted for 73% of all bacteraemias; S.
pneumoniae accounted for 45%. This hospital based study
emphasizes the dominance of S. pneumoniae in the etiol-
ogy of bacteraemia in The Gambia, consistent with previ-
ous etiology studies in this country [8-10].
S. pneumoniae has been identified as the dominant isolate
in bacteraemia elsewhere in Africa. Berkowitz [11] identi-
fied bacteraemia in 315 (5.8%) of 5397 children admitted
to a South African hospital; 23% died. S. pneumoniae
accounted for 23% of isolates, S. aureus 6%, Salmonella
species 20%, E. coli 13%, and H. influenzae 14%. Cotton
et al [12] documented 132 episodes of community-
acquired bacteraemia in hospitalized South African chil-
dren; 12% died. S. pneumoniae accounted for 33% of path-
ogens isolated, S. aureus 14%, N. meningitidis 11% and
other Gram negative organisms 18%. Berkley et al [3]
found that 866 (5.9%) of 14,787 children over 60 days of
age admitted to a rural hospital in Kenya had bacteraemia.
S. pneumoniae accounted for 30% of isolates, S. aureus 7%,
other Gram positive cocci 6%, NTS 19%, H. influenzae
15%, and E. coli 10%. In Malawi, Archibald et al [13]
found blood stream infection in 70 (30%) of 233 febrile
Table 1: Characteristics of the patients admitted with suspected bacteraemia.
Characteristics All (n = 871) Bacteraemia (n = 93) non-Bacteraemia (n = 574) p value
Age
2 mo–11 mo 200 (23.0) 24 (25.8) 110 (19.2)
11 mo–23 mo 207 (23.8) 18 (19.4) 127 (22.1)
2–5 years 166 (19.1) 23 (24.7) 112 (19.5)
6–15 years 113 (13.0) 13 (14.0) 77 (13.4)
>15 years 185 (21.2) 15 (16.1) 148 (25.8) 0.185
Male 475 (54.5) 59 (63.4) 312 (54.4) 0.102
Wet season admission 533 (61.2) 60 (64.5) 405 (70.6) 0.295
Duration of symptoms < 7 days (n = 849) 459 (54.1) 43 (47.8) 307 (55.1) 0.252
Weight for age z score <-2 (n = 693) 373 (53.8) 39 (51.3) 221 (51.0) 0.87
Temperature >= 38°C (n = 863) 364 (42.2) 48 (51.6) 229 (40.3) 0.041
Tachycardia (n = 738) 253 (34.2) 38 (46.9) 182 (37.3) 0.141
Raised respiratory rate (n = 677) 347 (51.3) 51 (62.2) 247 (55.2) 0.297
White Blood Cell Count (n = 852)
>= 10 × 109/L 484 (56.8) 64 (70.3) 306 (54.6) 0.005
>= 15 × 109/L 290 (34.0) 45 (49.5) 173 (30.8) <0.0001
Haemoglobin < 8 g/L (n = 602) 192 (32.0) 30 (41.1) 121 (31.8) 0.121
Sickle cell test positive (n = 243)a 57 (6.5) 8 (8.6) 13 (2.2) 0.144
Died in hospital 49 (5.5) 8 (8.3) 25 (4.3) 0.081
Specific Clinical Diagnoses
Pneumonia 332 (38.1) 40 (43.0) 207 (36.1) 0.198
Malaria (n = 676 tested)a 101 (11.6) 10 (10.8) 65 (11.3) 0.82
Severe Malnutrition 68 (7.8) 8 (8.6) 50 (8.7) 0.975
Tuberculosis 34 (3.9) 1 (1.1) 29 (5.1) 0.086
HIV/AIDS (n = 119 tested)a 36(4.1) 6 (6.4) 25 (4.4) 0.397
Gastroenteritis 36 (4.1) 1 (1.1) 24 (4.2) 0.145
Urinary tract infection 25 (2.9) 2 (2.2) 19 (3.3) 0.573
Nephrotic/Nephritic syndrome 23 (2.6) 1 (1.1) 17 (3.0) 0.297
Skin/soft tissue infection 20 (2.3) 3 (3.2) 15 (2.6) 0.74
Meningitis 13 (1.5) 1 (1.1) 9 (1.6) 0.716
Upper respiratory tract infection 12 (1.4) 0 9 (1.6) 0.252
Hepatititis 12 (1.4) 0 10 (1.7) 0.235
Bone/Joint infection 9 (1.0) 0 6 (1.0) 0.387
a For sickle cell, malaria and HIV tests, because the investigations were driven by clinical suspicion, the denominator for the % calculations remained 
the total number in each category.BMC Infectious Diseases 2007, 7:2 http://www.biomedcentral.com/1471-2334/7/2
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adults admitted to hospital, 70% of whom were HIV pos-
itive. S. pneumoniae accounted for 33% of isolates, Salmo-
nella species 19% and Gram positive cocci only 4%. M.
tuberculosis accounted for 29% of isolates, found exclu-
sively in HIV positive patients.
Salmonella  species have predominated in several other
African studies, particularly in high HIV prevalence set-
tings. Bahwere et al [14] identified 126 (15.9%) bacterae-
mias in 779 children admitted to a hospital in
Congo;19.4% died. Salmonella species accounted for 44%
of isolates. Gram positive bacteria accounted for only
10% of isolates. Ghiorghis et al [15] identified bacterae-
mia in 49 (7.7%) of 634 febrile children at an Ethiopian
hospital. Of the organisms isolated, Salmonella  species
accounted for 57%, streptococci 16%, staphylococci 14%,
and E. coli 6% and other Gram negative species 6%. Walsh
et al [16] reported that of 365 positive isolated from chil-
dren in Malawi, NTS accounted for 38% of isolates, H.
influenzae 6%, other Gram negative species 29%, S. pneu-
moniae 16%, other streptococci 8% and S. aureus 2%. Gor-
don et al [17] identified 449 pathogens from the blood of
adult patients in Blantyre: NTS accounted for 37% of iso-
lates and 30% were S. pneumoniae. NTS accounted for 70–
80% of all paediatric blood culture isolates in a hospital
in Western Zaire [18]. S. aureus was identified by Mere-
mikwu et al [19] as the cause of bacteraemia in 48.7% of
bacteraemias in children admitted to a Nigerian hospital,
44% were neonates. Differing criteria for patient selection,
variation in the standardisation of methods and bacterio-
Flow diagram of suspected bacteraemia patients according to blood culture results Figure 1
Flow diagram of suspected bacteraemia patients according to blood culture results.
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logical techniques used may explain some of the differ-
ences seen between studies.
Others have identified risk factors for bacteraemia in Afri-
can settings. Ghiorghis et al [15] found no difference in
nutritional status, age or temperature between febrile
bacteraemic cases and controls, but did find increased
WCC in those with salmonellae and in those with E. coli.
Bahwere et al [14], in their study dominated by Entero-
bacteraciae, also found no association with severe malnu-
trition. However, Cotton et al [12], Berkowitz et al [11]
and Friedland [20] identified severe malnutrition as a risk
factor for bacteraemia and death in South Africa.
Archibald et al [13] identified HIV positivity as a risk fac-
tor for bacteraemia in Malawi. HIV and malnutrition have
been shown to be independent risk factors for bacterae-
mia by Berkley et al [3].
In contrast to our study, seasonal variation in the etiology
of bacteraemia has been demonstrated in sub-Saharan
Africa. Bell et al [21], in a Malawi population with high
rates of HIV positivity, found that NTSpredominated in
the wet season while S. pneumoniae predominated in the
dry season. High prevalence of NTS in the wet season in
sub-Saharan Africa is thought to be associated with
malaria [22-24], although other, often site-specific, factors
should be considered as well. We had too few cases of NTS
to assess seasonal variation properly in this study.
Other studies from The Gambia confirm that high resist-
ance to penicillin is not yet prevalent here [10,6]. In con-
trast, high resistance was found to co-trimoxazole, which
is widely used at primary health care level. Evaluation of
an alternative antimicrobial for community management
of non-severe bacterial infections is now underway.
Although numbers of isolates were small, S aureus was in
general highly susceptible to cloxacillin, gentamicin and
chloramphenicol. Penicillin was the least effective antibi-
otic. Unlike several other developing countries where
resistance has been reported to these antimicrobials,
cheap and widely available antibiotics remain effective in
The Gambia. A larger study to give more precise estimates
Table 3: Antibiotic susceptibility of the 3 major organisms isolated and non-typhoidal salmonellae in relation to the number tested.
Organism n susceptible/n tested
Penicillin Ampicillin Cloxacillin Cotrim Gent Chloram Tetra Cipro
S. pneumoniae 39/40 42/42 ND 2/39 ND 40/41 27/41 ND
S. aureus 4/14 ND 14/14 10/15 15/15 15/15 5/15 ND
E. coli ND 0/9 ND 2/9 8/9 6/9 ND 9/9
NTa-
salmonellae
ND 4/7 ND 5/7 7/7 4/6 4/5 7/7
a Non-typhoidal
Table 2: Number of isolates/groups of isolates and their relative proportion (%) in each of 5 age bands and in each of 6 clinical 
diagnostic categories for those with Bacteraemia (n = 93).
Organism/group, n (% of row)
S. pneumoniae S. aureus Other Gram +ve E. coli NTa salmonellae Other Gram -ve
Age group
2 mo–11 mo 9 (37.5) 2 (8.3) 4 (16.7) 5 (20.8) 2 (8.3) 2 (8.3)
11 mo–23 mo 8 (44.4) 4 (22.2) 1 (5.6) 1 (5.6) 2 (11.1) 2 (11.1)
2–5 years 12 (52.2) 4 (17.4) 1 (4.4) 3 (13.0) 1 (4.4) 2 (8.7)
6–15 years 7 (53.4) 3 (23.1) 1 (7.7) 0 0 2 (15.4)
>15 years 6 (40.0) 4 (26.7) 1 (6.7) 0 3 (20.0) 1 (6.7)
All 42 (45.2) 17 (18.3) 8 (8.6) 9 (9.7) 8 (8.6) 9 (9.7)
Diagnostic category
Pneumonia 30 (78.9) 4 (10.5) 2 (5.3) 0 0 2 (5.3)
Sepsis 7 (29.2) 6 (25.0) 3 (12.5) 2 (8.3) 3 (12.5) 3 (12.5)
Malaria 0 1 (14.3) 0 2 (28.6) 2 (28.6) 2 (28.6)
HIV/AIDS 1 (16.7) 2 (33.3) 0 1 (16.7) 2 (33.3) 0
Severe Malnutrition 2 (40.0) 1 (20.0) 2 (40.0) 0 0 0
Other 2 (15.4) 3 (23.1) 1 (7.7) 4 (30.8) 1 (7.7) 2 (15.4)
a Non-typhoidalBMC Infectious Diseases 2007, 7:2 http://www.biomedcentral.com/1471-2334/7/2
Page 7 of 8
(page number not for citation purposes)
of antimicrobial susceptibility of isolates of E. coli and
NTS is required.
While this study represents 'real life' clinical practice in
this hospital and our data were prospectively gathered,
our approach has several limitations. A more formal study
would set strict criteria for taking blood for culture and
standardize all clinical and laboratory procedures. Such
an approach would enable certain tests to be routine, such
as HIV testing, and may involve sending certain isolates to
a reference laboratory for further identification. It is esti-
mated that 5–10% of inpatients in our hospital are HIV
positive (unpublished data). Despite having a standard-
ized form, we did not ask the clinician to record his/her
primary reason for taking a blood culture (we felt this
would be difficult to categorize), although 47% of
patients had a temperature of 37.5°C or more and 13% of
these had a pathogen isolated. As 80% of our study sub-
jects were under 5 years of age, interpretation of our find-
ings in the older age groups should be done cautiously.
We also cannot calculate an incidence rate of community-
acquired bacteraemia as the source population of this hos-
pital cannot be clearly defined and we did not obtain
blood cultures from a representative sample of outpatient
attendees [25].
Conclusion
This study confirms that bacteraemia is an important ill-
ness in hospital patients in The Gambia. It appears that
the most effective way to combat common severe bacterial
infections in Africa is through vaccination [26], a premise
supported by the virtual elimination of Hib disease from
The Gambia [4]. The success of the 9-valent pneumococ-
cal conjugate vaccine against pneumococcal disease in
The Gambia, [5] together with the results of the present
study, dictate that the introduction of a pneumococcal
vaccine into the routine vaccination schedule is a high pri-
ority. It is intended that the currently available 7-valent
pneumococcal conjugate vaccine will be introduced into
The Gambia. This vaccine could be expected to protect
against a substantial proportion of invasive pneumococ-
cal disease and may lead to improvements in resistance to
some antibiotics. However, it will not prevent disease by
pneumococci of serotypes 1 and 5, the most prevalent
serotypes in invasive pneumococcal disease in The Gam-
bia [6]. Therefore we will monitor the introduction of this
vaccine with a surveillance system to identify trends in the
incidence of invasive pneumococcal disease and changes
in serotype prevalence [27].
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